Navigation Links
ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
Date:11/7/2013

BAUDETTE, Minn., Nov. 7, 2013 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) today reported results for the three and nine months ended September 30, 2013.

Third quarter and year-to-date highlights include:

  • Third quarter net revenues of $7.8 million, reflecting an increase of 56% versus $5.0 million for the same period in 2012.
  • Third quarter net income from continuing operations of $1.0 million and third quarter EPS of $0.13.
  • Third quarter adjusted non-GAAP net income from continuing operations of $1.5 million and adjusted non-GAAP EPS from continuing operations of $0.16.
  • Third quarter adjusted non-GAAP EBITDA of $1.7 million, reflecting an increase of 539% versus the prior year period.
  • ANI announced an agreement for the development and marketing of an oral soft gel prescription product with Sofgen Pharmaceuticals.
  • Year-to-date net revenues of $19.5 million increased 30% versus $15.0 million in the first nine months of 2012.
  • Year-to-date adjusted non-GAAP EBITDA of $3.6 million increased 107% over the prior year period.
  • Net revenues and Adjusted Non-GAAP EBITDAThree months ended September 30,Nine months ended  September 30,2013201220132012Net revenues

    $  7,836,222

    $  5,036,024

    $  19,549,670

    $ 15,049,619Adjusted Non-GAAP EBITDA(a)

    $  1,692,667

    $
    264,962

    $
    3,579,067

    $   1,728,030(a) See Table 2 for US GAAP reconciliation.Arthur S. Przybyl, President and CEO, stated, "Our revenues continue to exhibit strong organic growth, increasing by 56% to $7.8 million in the third quarter.  At the same time, our cost of sales decreased by 12 percentage points, from 46% to 34%, as we continue to grow sales in our higher margin products.  We expect our fourth quart
    '/>"/>

    SOURCE ANI Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Vanda Pharmaceuticals Reports Third Quarter 2013 Results
    2. Questcor Pharmaceuticals to Present at the 2013 Credit Suisse Annual Healthcare Conference
    3. Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
    4. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
    5. Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
    6. AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results
    7. Cumberland Pharmaceuticals Reports Third Quarter Financial Results
    8. Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results
    9. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
    10. Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
    11. Jazz Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference on November 12
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... INC. (NYSE: RMD ) today announced that it ... 30, 2014 results on Thursday, July 31, 2014, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
    (Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
    (Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
    Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
    ... Calif., Jan. 10, 2012  Nine prominent science institutions have ... and careers site for graduate level life science professionals.  ... all among the top graduate programs in the life ... Stony Brook, Louisville, Rochester, University of Texas Medical Branch, ...
    ... Jan. 10, 2012 The AquaLab Vapor Sorption ... scientists to better understand moisture in products and pinpoint ... by temperature and humidity changes can reveal important details ... type of measurement is called an isotherm.  ...
    Cached Medicine Technology:Bio Careers Adds 9 Universities, Reaching 40 Members 2New AquaLab Vapor Sorption Analyzer Puts Isotherm Technology Within Financial Reach of Food and Pharmaceutical Scientists 2
    (Date:7/12/2014)... Miami, FL (PRWEB) July 12, 2014 Fresh ... Brazil and Colombia will meet on September 5th at ... allowed the world to see some of the brightest stars ... Diehard soccer fans in Miami will be treated to some ... , Brazil is currently ranked as the third best team ...
    (Date:7/12/2014)... The "North American Interventional ... by Angioplasty Balloon (Plain/Old, Cutting), Stent ... Filter (Retrievable), Endovascular Stent Graft - ... the major market drivers, restraints, and ... , Browse 108 market data tables ...
    (Date:7/12/2014)... July 12, 2014 The fastest-growing mobile ... test and measurement of LTE networks continues to grow ... for smart devices have increased mobile data traffic, which ... Measurement (CT&M) market. Communications Test and Measurement equipment comply ... , The Communications Test and Measurement Market is estimated ...
    (Date:7/12/2014)... News) -- Burn injuries increase in the summer as people ... experts. Among those most vulnerable to these seasonal fire hazards: ... often get burned by putting their hands on the side ... burn unit at Loyola University Medical Center in Maywood, Ill., ... of ,When you play with fire, you get burned, is ...
    (Date:7/12/2014)... Pittsburgh, PA (PRWEB) July 12, 2014 ... embarrassing, so one of two inventors from Ashland, Va., ... to do this. "This inspired us to conceive of ... prototype of the patent-pending KIDNEY KOVER, which provides an ... bag. It avoids embarrassment, as well as promotes comfort ...
    Breaking Medicine News(10 mins):Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:Burn Injuries More Common in Summer 2
    ... realize international health goals aiming to improve maternal health, ... is crucial. In an editorial published this week entitled ... editors argue that action on maternal health must ... much as it does access to basic medical care. ...
    ... as hair, nails, sweat glands and mammary glandsare rare ... States, according to a report in the June issue ... JAMA/Archives journals. "Cutaneous appendageal carcinomas are a rare ... that frequently present a diagnostic challenge," the authors write ...
    ... study in the journal Respirology reveals that ... of chronic obstructive pulmonary disease (COPD) experience longer time ... risk of death, compared to those without diabetes., High ... impairment of immune responses. Researchers led by Dr. Ali ...
    ... June 21 (HealthDay News) -- Using ear tubes to treat ... a new study finds. , U.S. researchers studied 78 ears ... tubes before cochlear implants. In 46 (59 percent) of the ... In all the other cases, the ear tubes were left ...
    ... C-section babies seem more likely to develop allergies, ... -- Babies who are born vaginally pick up different ... potentially affecting how their immune systems develop, a new ... insight into why babies born through cesarean sections appear ...
    ... of an ancient language provides new insights into the ... world. The study, "Dvandvas, Blocking, and the Associative: The ... in the June 2010 issue of the scholarly journal ... Stanford University. A preprint version is available on line ...
    Cached Medicine News:Health News:Cancers of sweat glands, other skin-related structures may be increasing in United States 2Health News:Ear Tubes Appear to Be Safe Before Cochlear Implantation 2Health News:Delivery Method May Determine the Bacteria Babies Acquire 2Health News:Delivery Method May Determine the Bacteria Babies Acquire 3Health News:The 'bumpy ride' of linguistic change 2
    ... Donor Screening: The Procleix System ... safety to the nation's blood supply. It ... target capture, and a unique nucleic acid ... HIV-1/HCV Assay can simultaneously detect the presence ...
    ... Test (Reveal Test) is MedMiras flagship rapid ... human serum or plasma against HIV-1 that ... to HIV infection. The Reveal Test is ... and is comprised of a single-use test ...
    The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
    X-Hair Trephines...
    Medicine Products: